Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0N2DP
|
||||
Former ID |
DNC005312
|
||||
Drug Name |
N*6*-Cyclooctyl-N*2*-phenyl-9H-purine-2,6-diamine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527647] | ||
Structure |
Download2D MOL |
||||
Formula |
C19H24N6
|
||||
Canonical SMILES |
C1CCCC(CCC1)NC2=NC(=NC3=C2NC=N3)NC4=CC=CC=C4
|
||||
InChI |
1S/C19H24N6/c1-2-5-9-14(10-6-3-1)22-18-16-17(21-13-20-16)24-19(25-18)23-15-11-7-4-8-12-15/h4,7-8,11-14H,1-3,5-6,9-10H2,(H3,20,21,22,23,24,25)
|
||||
InChIKey |
MSEVQUIRSAPIPS-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Adenosine A3 receptor | Target Info | Inhibitor | [527647] | |
Adenosine A1 receptor | Target Info | Inhibitor | [527647] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
RANKL Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.